𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder

✍ Scribed by Kaplan, Alicia; Franzen, Michael D.; Nickell, P. V.; Ransom, Danielle; Lebovitz, Paul J.


Book ID
120982710
Publisher
Informa plc
Year
2013
Tongue
English
Weight
643 KB
Volume
18
Category
Article
ISSN
1365-1501

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Duloxetine in the treatment of irritable
✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal